Companies: 10,795·Total market cap: $144.5T
Gracell Biotechnologies Inc.

Gracell Biotechnologies Inc.

GRCLNASDAQHealthcare
$10.25
+$0.01(+0.05%)
Market Cap$197973420
P/E Ratio
52W High$10.435
52W Low$1.4

Gracell Biotechnologies Inc.(GRCL)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · GRCL · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2022-122021-122020-122019-122018-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Margin %(computed)100.00%
Operating Expenses
R&D Expenses$0.49B$0.33B$0.17B$0.12B$0.05B
G&A Expenses$0.14B$0.14B$0.05B$0.03B$0.01B
Total Operating Expenses$0.62B$0.46B$0.21B$0.15B$0.06B
Operating Income($0.62B)($0.46B)($0.21B)($0.15B)($0.06B)
Operating Margin %(computed)
Interest Income$0.02B$0.01B$0.00B$0.00B$0.00B
Interest Expense$0.01B$0.01B$0.00B$0.00B$0.00B
Income Before Tax($0.61B)($0.45B)($0.21B)($0.14B)($0.06B)
Income Tax Expense$0.00B$0.00B($0.01B)($0.01B)$0.00B
Net Income($0.61B)($0.47B)($0.20B)($0.13B)($0.06B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-44.85$-35.40$-15.05$-33.35$-15.35
Wtd Avg Shares0.01B0.01B0.01B0.00B0.00B
EBITDA($0.57B)($0.39B)($0.20B)($0.14B)($0.06B)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · CNY · B

深入了解Gracell Biotechnologies Inc.

关于Gracell Biotechnologies Inc.(GRCL)损益表

Gracell Biotechnologies Inc.(GRCL)损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年,GRCL实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.61B)(净利率—)。

常见问题

GRCL · 4 问

Gracell Biotechnologies Inc.(GRCL)2022财年营收为$0.00B,同比down100.0%。

GRCL revenueGRCL salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09